Tapewire

Nasdaq · USD

PODD

INSULET CORP

Export transactions ↓
Tapewire entity
3516
SEC CIK
0001145197
Parsed reports
585

Last 12 months

Inside the activity.

6 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202511
Jan 202600
Feb 202620
Mar 202600
Apr 202600
May 202600
Jun 202621
Jul 202600
Aug 202610
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 01, 2022 Filed Jul 6, 2022 20:17 UTC Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 7,930 $0.00 Strike: $46.22 $0.00
Disclosure

SEC source: 0001127602-22-018935 · form4.xml · derivative · entry 7

Petrovic Shacey · CIK 0001631895 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,445

Underlying: Common Stock · 7,930 shares

Expires 2027-02-22

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 20:17 UTC Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 7,070 $0.00 Strike: $29.26 $0.00
Disclosure

SEC source: 0001127602-22-018935 · form4.xml · derivative · entry 6

Petrovic Shacey · CIK 0001631895 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,070 shares

Expires 2026-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 20:17 UTC SaleCommon Stock 15,000 $222.90 $3,343,500.00
Disclosure

SEC source: 0001127602-22-018935 · form4.xml · nonDerivative · entry 3

Petrovic Shacey · CIK 0001631895 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,695

F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.

F3 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $214.16 to $226.52. Specifically: 21 shares were sold in the range of $214.16 to $214.26 per share, with a weighted average share price of $214.26; 23 shares were sold at a price $215.19; 400 shares were sold in the range of $216.59 to $217.58 per share, with a weighted average share price of $217.09; 106 shares were sold in the range of $218.83 to $219.81 per share, with a weighted average share price of $218.89; 1,299 shares were sold in the range of $220.09 to $221.02 per share, with a weighted average share price of $220.47; 2,988 shares were sold in the range of $221.21 to $222.18 per share, with a weighted average share price of $221.68; 3,930 shares were sold in the range of $222.27 to $223.27 per share, with a weighted average share price of $222.81; 2,812 shares were sold in the range of $223.35 to $224.34 per share, with a weighted average share price of $223.75; 2,113 shares were sold in the range of $224.37 to $225.33 per share, with a weighted average share price of $224.71 and 1,308 shares were sold in the range of $225.57 to $226.52 per share, with a weighted average share price of $226.03. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 20:17 UTC Exercise / conversionCommon Stock 7,930 $46.22 $366,524.60
Disclosure

SEC source: 0001127602-22-018935 · form4.xml · nonDerivative · entry 2

Petrovic Shacey · CIK 0001631895 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.

Read SEC document
July 01, 2022 Filed Jul 6, 2022 20:17 UTC Exercise / conversionCommon Stock 7,070 $29.26 $206,868.20
Disclosure

SEC source: 0001127602-22-018935 · form4.xml · nonDerivative · entry 1

Petrovic Shacey · CIK 0001631895 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,765

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.

F2 · balance_after: Includes 88 shares acquired under the Insulet Corporation Employee Stock Purchase Plan on May 31, 2022.

Read SEC document
June 15, 2022 Filed Jul 6, 2022 20:14 UTC GiftCommon Stock 808 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-018928 · form4.xml · nonDerivative · entry 2

MINOGUE MICHAEL R · CIK 0001286370 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 8,921

F1 · shares: This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse. The reporting person's spouse is a trustee of the trust.

Read SEC document
June 15, 2022 Filed Jul 6, 2022 20:14 UTC GiftCommon Stock 808 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-018928 · form4.xml · nonDerivative · entry 1

MINOGUE MICHAEL R · CIK 0001286370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,009

F1 · shares: This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse. The reporting person's spouse is a trustee of the trust.

Read SEC document
June 06, 2022 Filed Jun 7, 2022 20:50 UTC
Alpuche CharlesEVP & Chief Operating Officer
SaleCommon Stock 6,000 $215.32 $1,291,920.00
Disclosure

SEC source: 0001127602-22-017001 · form4.xml · nonDerivative · entry 1

Alpuche Charles · CIK 0001665678 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,899

F1 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $212.08 to $218.41. Specifically:400 shares were sold in the range of $212.08 to $212.99, with a weighted average share price of $212.65; 300 shares were sold in the range of $213.26 to $213.84, with a weighted average share price of $213.53; 800 shares were sold in the range of $214.21 to $214.55, with a weighted average share price of $214.34; 2,898 shares were sold in the range of $215.01 to $215.98, with a weighted average share price of $215.45; 1,301 shares were sold in the range of $216.01 to $216.70, with a weighted average share price of $216.33; 201 shares were sold in the range of $217.03 to $217.24, with a weighted average share price of $217.14 and 100 shares were sold at a price of $218.41. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

F2 · balance_after: Includes 88 shares acquired under the Insulet Corporation Employee Stock Purchase Plan on May 31, 2022.

Read SEC document
June 03, 2022 Filed Jun 6, 2022 20:10 UTC
Budden LaurenGroup VP, CAO and Controller
Tax withholdingCommon Stock 366 $212.57 $77,800.62
Disclosure

SEC source: 0001127602-22-016870 · form4.xml · nonDerivative · entry 1

Budden Lauren · CIK 0001774891 · Group VP, CAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,578

F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.

F2 · balance_after: Includes 71 shares acquired under the Insulet Corporation Employee Stock Purchase Plan on May 31, 2022.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 21:17 UTC
Manea DanSVP, Chief HR Officer
Tax withholdingCommon Stock 234 $207.38 $48,526.92
Disclosure

SEC source: 0001127602-22-016444 · form4.xml · nonDerivative · entry 1

Manea Dan · CIK 0001811448 · SVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,358

F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.

F2 · balance_after: Includes 88 shares acquired under the Insulet Corporation Employee Stock Purchase Plan on May 31, 2022.

Read SEC document
June 01, 2022 Filed Jun 2, 2022 20:33 UTC
Hollingshead JamesDirector · President and CEO
GrantCommon Stock 21,699 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-016388 · form4.xml · nonDerivative · entry 1

Hollingshead James · CIK 0001570610 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,569

F1 · shares: Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis.

Read SEC document
May 24, 2022 Filed May 26, 2022 20:12 UTC GrantCommon Stock 1,009 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-015767 · form4.xml · nonDerivative · entry 1

Scannell Timothy J · CIK 0001451533 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,396

F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs vest in full on April 30, 2023 and are settled in shares of common stock on a one-for-one basis.

Read SEC document
May 24, 2022 Filed May 26, 2022 20:14 UTC GrantCommon Stock 1,009 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-015768 · form4.xml · nonDerivative · entry 1

WEATHERMAN ELIZABETH H · CIK 0001188681 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,241

F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs vest in full on April 30, 2023 and are settled in shares of common stock on a one-for-one basis.

Read SEC document
May 24, 2022 Filed May 26, 2022 20:11 UTC GrantCommon Stock 1,009 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-015766 · form4.xml · nonDerivative · entry 1

Nevinny Corinne H · CIK 0001182467 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,167

F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs vest in full on April 30, 2023 and are settled in shares of common stock on a one-for-one basis.

Read SEC document
May 24, 2022 Filed May 26, 2022 20:10 UTC GrantCommon Stock 1,009 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-015765 · form4.xml · nonDerivative · entry 3

MINOGUE MICHAEL R · CIK 0001286370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,817

F2 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs vest in full on April 30, 2023 and are settled in shares of common stock on a one-for-one basis.

Read SEC document
May 24, 2022 Filed May 26, 2022 20:08 UTC GrantCommon Stock 1,009 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-015763 · form4.xml · nonDerivative · entry 1

Hopfield Jessica · CIK 0001648715 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,694

F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs vest in full on April 30, 2023 and are settled in shares of common stock on a one-for-one basis.

Read SEC document
May 24, 2022 Filed May 26, 2022 20:07 UTC GrantCommon Stock 1,009 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-015762 · form4.xml · nonDerivative · entry 1

Frederick Wayne A.I. · CIK 0001802241 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,833

F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs vest in full on April 30, 2023 and are settled in shares of common stock on a one-for-one basis.

Read SEC document
May 24, 2022 Filed May 26, 2022 20:05 UTC GrantCommon Stock 1,009 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-015761 · form4.xml · nonDerivative · entry 1

BORIO LUCIANA · CIK 0001859226 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,007

F1 · shares: Annual equity award in the form of restricted stock units ("RSUs"). These RSUs vest in full on April 30, 2023 and are settled in shares of common stock on a one-for-one basis.

Read SEC document
April 04, 2022 Filed Apr 5, 2022 20:17 UTC
Petrovic ShaceyDirector · President and CEO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $29.26 $0.00
Disclosure

SEC source: 0001127602-22-011550 · form4.xml · derivative · entry 6

Petrovic Shacey · CIK 0001631895 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,070

Underlying: Common Stock · 15,000 shares

Expires 2026-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.

Read SEC document
April 04, 2022 Filed Apr 5, 2022 20:17 UTC
Petrovic ShaceyDirector · President and CEO
SaleCommon Stock 15,000 $273.25 $4,098,750.00
Disclosure

SEC source: 0001127602-22-011550 · form4.xml · nonDerivative · entry 4

Petrovic Shacey · CIK 0001631895 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,607

F2 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.

F3 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $270.79 to $279.59. Specifically: 4,146 shares were sold in the range of $270.79 to $271.77 per share, with a weighted average share price of $271.35; 1,928 shares were sold in the range of $271.79 to $272.73 per share, with a weighted average share price of $272.10; 3,111 shares were sold in the range of $272.80 to $273.77 per share, with a weighted average share price of $273.30; 3,618 shares were sold in the range of $273.78 to $274.77 per share, with a weighted average share price of $274.21; 1,413 shares were sold in the range of $274.78 to $275.35 per share, with a weighted average share price of $275.08; 200 shares were sold in the range of $276.09 to $276.37 per share, with a weighted average share price of $276.23; 142 shares were sold in the range of $277.64 to $278.39 per share, with a weighted average share price of $278.20 and 442 shares were sold in the range of $278.66 to $279.59 per share, with a weighted average share price of $279.28. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 04, 2022 Filed Apr 5, 2022 20:17 UTC
Petrovic ShaceyDirector · President and CEO
Exercise / conversionCommon Stock 15,000 $29.26 $438,900.00
Disclosure

SEC source: 0001127602-22-011550 · form4.xml · nonDerivative · entry 3

Petrovic Shacey · CIK 0001631895 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,607

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 20:15 UTC SaleCommon Stock 1,455 $275.60 $400,998.00
Disclosure

SEC source: 0001127602-22-011546 · form4.xml · nonDerivative · entry 1

McMillan Wayde D. · CIK 0001768648 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,354

F1 · shares: The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.

F2 · price: The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $269.18 to $278.63. Specifically:108 shares were sold at $269.18 per share; 20 shares were sold at $273.24 per share; 361 shares were sold in the range of $274.05 to $274.98 per share, with a weighted average share price of $274.63; 351 shares were sold in the range of $275.16 to $276.01 per share, with a weighted average share price of $275.65; 395 shares were sold in the range of $276.48 to $277.38 per share, with a weighted average share price of $276.87; 192 shares were sold in the range of $277.48 to $278.45 per share, with a weighted average share price of $278.13; 28 shares were sold in the range of $278.48 to $278.63 per share, with a weighted average share price of $278.58. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 20:11 UTC
Kapples John W.SVP and General Counsel
Tax withholdingCommon Stock 1,453 $279.02 $405,416.06
Disclosure

SEC source: 0001127602-22-011534 · form4.xml · nonDerivative · entry 1

Kapples John W. · CIK 0001663408 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,655

F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.

Read SEC document
March 17, 2022 Filed Apr 5, 2022 20:17 UTC
Petrovic ShaceyDirector · President and CEO
GiftCommon Stock 19,903 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-011550 · form4.xml · nonDerivative · entry 2

Petrovic Shacey · CIK 0001631895 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By SP Trust

Disclosed balance after: 26,304

F1 · shares: On March 17, 2022, the reporting person transferred 19,903 shares of Insulet common stock to a family trust of which the reporting person is a trustee. The reporting person and members of her immediate family are beneficiaries of the trust.

Read SEC document
March 17, 2022 Filed Apr 5, 2022 20:17 UTC
Petrovic ShaceyDirector · President and CEO
GiftCommon Stock 19,903 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-011550 · form4.xml · nonDerivative · entry 1

Petrovic Shacey · CIK 0001631895 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,607

F1 · shares: On March 17, 2022, the reporting person transferred 19,903 shares of Insulet common stock to a family trust of which the reporting person is a trustee. The reporting person and members of her immediate family are beneficiaries of the trust.

Read SEC document
March 15, 2022 Filed May 26, 2022 20:10 UTC GiftCommon Stock 3,549 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-015765 · form4.xml · nonDerivative · entry 2

MINOGUE MICHAEL R · CIK 0001286370 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 8,113

F1 · shares: This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse. The reporting person's spouse is a trustee of the trust.

Read SEC document
March 15, 2022 Filed May 26, 2022 20:10 UTC GiftCommon Stock 3,549 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-015765 · form4.xml · nonDerivative · entry 1

MINOGUE MICHAEL R · CIK 0001286370 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 808

F1 · shares: This transaction represents the transfer of common stock by bona fide gift from the reporting person to a trust held for the benefit of the reporting person's spouse. The reporting person's spouse is a trustee of the trust.

Read SEC document
March 01, 2022 Filed Mar 2, 2022 21:43 UTC Tax withholdingCommon Stock 3,134 $260.84 $817,472.56
Disclosure

SEC source: 0001127602-22-007729 · form4.xml · nonDerivative · entry 2

McMillan Wayde D. · CIK 0001768648 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,809

F2 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:47 UTC
Spears Michael PSVP, RA and Compliance
GrantEmployee Stock Option (Right to Buy) · Derivative 1,820 $0.00 Strike: $264.69 $0.00
Disclosure

SEC source: 0001127602-22-007732 · form4.xml · derivative · entry 2

Spears Michael P · CIK 0001667779 · SVP, RA and Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,820

Underlying: Common Stock · 1,820 shares

Expires 2032-02-28

F2 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:47 UTC
Spears Michael PSVP, RA and Compliance
GrantCommon Stock 661 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-007732 · form4.xml · nonDerivative · entry 1

Spears Michael P · CIK 0001667779 · SVP, RA and Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,160

F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:44 UTC
Petrovic ShaceyDirector · President and CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 21,842 $0.00 Strike: $264.69 $0.00
Disclosure

SEC source: 0001127602-22-007731 · form4.xml · derivative · entry 4

Petrovic Shacey · CIK 0001631895 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,842

Underlying: Common Stock · 21,842 shares

Expires 2032-02-28

F2 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:44 UTC
Petrovic ShaceyDirector · President and CEO
GrantCommon Stock 7,933 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-007731 · form4.xml · nonDerivative · entry 1

Petrovic Shacey · CIK 0001631895 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,096

F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:43 UTC GrantEmployee Stock Option (Right to Buy) · Derivative 6,500 $0.00 Strike: $264.69 $0.00
Disclosure

SEC source: 0001127602-22-007729 · form4.xml · derivative · entry 3

McMillan Wayde D. · CIK 0001768648 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires 2032-02-28

F3 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:43 UTC GrantCommon Stock 2,361 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-007729 · form4.xml · nonDerivative · entry 1

McMillan Wayde D. · CIK 0001768648 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,943

F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:41 UTC
Manea DanSVP, Chief HR Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 1,950 $0.00 Strike: $264.69 $0.00
Disclosure

SEC source: 0001127602-22-007726 · form4.xml · derivative · entry 2

Manea Dan · CIK 0001811448 · SVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,950

Underlying: Common Stock · 1,950 shares

Expires 2032-02-28

F2 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:41 UTC
Manea DanSVP, Chief HR Officer
GrantCommon Stock 708 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-007726 · form4.xml · nonDerivative · entry 1

Manea Dan · CIK 0001811448 · SVP, Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,504

F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:39 UTC
Kapples John W.SVP and General Counsel
GrantEmployee Stock Option (Right to Buy) · Derivative 3,770 $0.00 Strike: $264.69 $0.00
Disclosure

SEC source: 0001127602-22-007723 · form4.xml · derivative · entry 2

Kapples John W. · CIK 0001663408 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,770

Underlying: Common Stock · 3,770 shares

Expires 2032-02-28

F2 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:39 UTC
Kapples John W.SVP and General Counsel
GrantCommon Stock 1,369 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-007723 · form4.xml · nonDerivative · entry 1

Kapples John W. · CIK 0001663408 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,108

F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:38 UTC
Budden LaurenGroup VP, CAO and Controller
GrantEmployee Stock Option (Right to Buy) · Derivative 1,170 $0.00 Strike: $264.69 $0.00
Disclosure

SEC source: 0001127602-22-007721 · form4.xml · derivative · entry 2

Budden Lauren · CIK 0001774891 · Group VP, CAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,170

Underlying: Common Stock · 1,170 shares

Expires 2032-02-28

F2 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:38 UTC
Budden LaurenGroup VP, CAO and Controller
GrantCommon Stock 1,369 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-007721 · form4.xml · nonDerivative · entry 1

Budden Lauren · CIK 0001774891 · Group VP, CAO and Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,873

F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:34 UTC
Christensen BretEVP and CCO
GrantEmployee Stock Option (Right to Buy) · Derivative 6,500 $0.00 Strike: $264.69 $0.00
Disclosure

SEC source: 0001127602-22-007716 · form4.xml · derivative · entry 2

Christensen Bret · CIK 0001707443 · EVP and CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires 2032-02-28

F2 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:34 UTC
Christensen BretEVP and CCO
GrantCommon Stock 2,361 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-007716 · form4.xml · nonDerivative · entry 1

Christensen Bret · CIK 0001707443 · EVP and CCO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,363

F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:32 UTC
Benjamin EricSVP, Innovation and Strategy
GrantEmployee Stock Option (Right to Buy) · Derivative 4,160 $0.00 Strike: $264.69 $0.00
Disclosure

SEC source: 0001127602-22-007714 · form4.xml · derivative · entry 2

Benjamin Eric · CIK 0001731734 · SVP, Innovation and Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,160

Underlying: Common Stock · 4,160 shares

Expires 2032-02-28

F2 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:32 UTC
Benjamin EricSVP, Innovation and Strategy
GrantCommon Stock 1,511 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-007714 · form4.xml · nonDerivative · entry 1

Benjamin Eric · CIK 0001731734 · SVP, Innovation and Strategy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,888

F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:30 UTC
Alpuche CharlesEVP & Chief Operating Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 6,500 $0.00 Strike: $264.69 $0.00
Disclosure

SEC source: 0001127602-22-007711 · form4.xml · derivative · entry 2

Alpuche Charles · CIK 0001665678 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,500

Underlying: Common Stock · 6,500 shares

Expires 2032-02-28

F2 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
February 28, 2022 Filed Mar 2, 2022 21:30 UTC
Alpuche CharlesEVP & Chief Operating Officer
GrantCommon Stock 2,361 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-007711 · form4.xml · nonDerivative · entry 1

Alpuche Charles · CIK 0001665678 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,811

F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis.

Read SEC document
February 28, 2022 Filed Mar 4, 2022 21:20 UTC Amendment
Petrovic ShaceyDirector · President and CEO
GrantEmployee Stock Option (Right to Buy) · Derivative 17,473 $0.00 Strike: $264.69 $0.00
Disclosure

SEC source: 0001127602-22-008265 · form4a.xml · derivative · entry 4

Petrovic Shacey · CIK 0001631895 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,473

Underlying: Common Stock · 17,473 shares

Expires 2032-02-28

F3 · shares: Due to an administrative error, this grant was originally reported as an option to purchase 21,842 shares rather than an option to purchase 17,473 shares.

F4 · derivative.exercise_date: Annual Non-Qualified Stock Option ("Option") Award. The Options become exercisable in substantially equal installments on each of the first, second, third and fourth anniversaries of the grant date.

Read SEC document
February 28, 2022 Filed Mar 4, 2022 21:20 UTC Amendment
Petrovic ShaceyDirector · President and CEO
GrantCommon Stock 6,347 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-008265 · form4a.xml · nonDerivative · entry 1

Petrovic Shacey · CIK 0001631895 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,510

F1 · shares: Annual Restricted Stock Unit ("RSU") award. RSUs vest in equal installments on each of the first, second and third anniversaries of the grant date and are settled in shares of common stock on a one-for-one basis.

F2 · shares: Due to an administrative error, this grant was originally reported as 7,933 RSUs rather than 6,347 RSUs.

Read SEC document
February 26, 2022 Filed Feb 28, 2022 21:20 UTC
Spears Michael PSVP, RA and Compliance
Tax withholdingCommon Stock 302 $262.37 $79,235.74
Disclosure

SEC source: 0001127602-22-007014 · form4.xml · nonDerivative · entry 1

Spears Michael P · CIK 0001667779 · SVP, RA and Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,499

F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.

Read SEC document
February 26, 2022 Filed Feb 28, 2022 21:19 UTC
Petrovic ShaceyDirector · President and CEO
Tax withholdingCommon Stock 1,124 $262.37 $294,903.88
Disclosure

SEC source: 0001127602-22-007011 · form4.xml · nonDerivative · entry 1

Petrovic Shacey · CIK 0001631895 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,163

F1 · shares: This transaction represents the withholding of shares received upon the vesting of restricted stock units to cover the associated tax obligations.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.